GenomeDx Biosciences
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, GenomeDx Biosciences sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
GenomeDx Biosciences: 4 sponsored US clinical trials, none currently recruiting.
GenomeDx Biosciences sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. The most-studied condition in this pipeline is Prostate Cancer, with 1 trials.
Upper-quartile sponsor footprint
GenomeDx Biosciences sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
NCT02080689
Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists
NCT02034812
Multi-site Decision Impact Study for Decipher
NCT02034825
Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations
NCT02020876
Therapeutic Areas
How the GenomeDx Biosciences archive is shaped
4 indexed studies, none listed as recruiting (0% open); 4 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Prostate Cancer (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
GenomeDx Biosciences: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
GenomeDx Biosciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this GenomeDx Biosciences page
4 registered trials is a research-attention snapshot, not an endorsement of GenomeDx Biosciences or any single study.
- None of GenomeDx Biosciences's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Prostate Cancer is the condition GenomeDx Biosciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. GenomeDx Biosciences pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.